ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 105 filers reported holding ALBIREO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,147,000 | -23.2% | 57,758 | +15.3% | 0.01% | +22.2% |
| Q1 2022 | $1,494,000 | -0.2% | 50,085 | -22.1% | 0.01% | +12.5% |
| Q4 2021 | $1,497,000 | +14.7% | 64,288 | +53.7% | 0.01% | -11.1% |
| Q3 2021 | $1,305,000 | +22.7% | 41,818 | +38.2% | 0.01% | +28.6% |
| Q2 2021 | $1,064,000 | -38.8% | 30,253 | -38.7% | 0.01% | -41.7% |
| Q1 2021 | $1,739,000 | +514.5% | 49,328 | +553.1% | 0.01% | +300.0% |
| Q4 2020 | $283,000 | – | 7,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 174,791 | $6,556,000 | 3.03% |
| Sio Capital Management, LLC | 354,210 | $13,286,000 | 2.72% |
| Birchview Capital, LP | 92,000 | $3,451,000 | 1.99% |
| Chicago Capital, LLC | 618,263 | $23,191,000 | 1.04% |
| Perceptive Advisors | 2,360,139 | $88,529,000 | 0.95% |
| Endurant Capital Management LP | 42,292 | $1,586,000 | 0.57% |
| Artal Group S.A. | 700,000 | $26,257,000 | 0.56% |
| Cormorant Asset Management, LP | 500,000 | $18,755,000 | 0.45% |
| Samsara BioCapital, LLC | 100,000 | $3,751,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 257,372 | $9,654,000 | 0.34% |